A substantial acquisition of company stock options by DEBRA MORRIS, Board Member at Progyny PGNY was reported on January 21, based on a new SEC filing.
What Happened: MORRIS, Board Member at Progyny, engaged in a derivative transaction according to a Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission. This involved the acquisition of stock options for 44,000 shares of PGNY, providing the right to purchase the company's stock at an exercise price of $20.62 per share.
Progyny shares are trading down 0.0% at $21.48 at the time of this writing on Wednesday morning. Since the current price is $21.48, this makes MORRIS's 44,000 shares worth $37,839.
All You Need to Know About Progyny
Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.
Progyny: Delving into Financials
Revenue Growth: Progyny displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 2.04%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Insights into Profitability:
-
Gross Margin: The company issues a cost efficiency warning with a low gross margin of 20.67%, indicating potential difficulties in maintaining profitability compared to its peers.
-
Earnings per Share (EPS): Progyny's EPS lags behind the industry average, indicating concerns and potential challenges with a current EPS of 0.12.
Debt Management: Progyny's debt-to-equity ratio is below the industry average. With a ratio of 0.04, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Understanding Financial Valuation:
-
Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 35.8, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
-
Price to Sales (P/S) Ratio: The Price to Sales ratio is 1.83, which is lower than the industry average. This suggests a possible undervaluation based on sales performance.
-
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): With an impressive EV/EBITDA ratio of 23.53, Progyny demonstrates exemplary market valuation, surpassing industry averages.
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
The Importance of Insider Transactions
Investors should view insider transactions as part of a multifaceted analysis and not rely solely on them for decision-making.
Exploring the legal landscape, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.
Highlighted by a company insider's new purchase, there's a positive anticipation for the stock to rise.
But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
A Closer Look at Important Transaction Codes
Taking a closer look at transactions, investors often prioritize those unfolding in the open market, meticulously cataloged in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A signifies a grant, award, or other acquisition of securities from the company.
Check Out The Full List Of Progyny's Insider Trades.
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. Click here for access.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.